Molecular Templates Inc Files For Shelf Of Up To 11.01M Shares Of Common Stock By Selling Stockholders
Molecular Templates Inc Files For Shelf Of Up To 11.01M Shares Of Common Stock By Selling Stockholders
Molecular Templates to Cut 30% of Staff, Chief Medical Officer
By Ben Glickman Molecular Templates said it would lay off about 30% of its workforce and cut its chief medical officer as it looks to stretch its resources. The Austin, Texas-based biopharmaceutical
Molecular Templates Inc Announces Layoffs, CMO Resignation
Molecular Templates Inc Says Reduction In Force Would Reduce Company's Current Workforce By ~30%; Approved A Reduction In Force; Expects That Reduction In Force Will Be Complete By End Of April 2024
Molecular Templates Inc Says Reduction In Force Would Reduce Company's Current Workforce By ~30%; Approved A Reduction In Force; Expects That Reduction In Force Will Be Complete By End Of April 2024
Molecular Templates, Inc. (NASDAQ:MTEM) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough
The Molecular Templates, Inc. (NASDAQ:MTEM) share price has fared very poorly over the last month, falling by a substantial 47%. For any long-term shareholders, the last month ends a year to forget
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersJaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $
What's Going On With Molecular Templates Stock?
Molecular Templates, Inc (NASDAQ:MTEM) shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients with PD-L1+ solid tumors. The Details:Molecular Templ
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals Among Healthcare Movers
Molecular Templates Presents Interim Data From MT-6402 Phase I Study In Patients With PD-L1+ Solid Tumors At 2024 AACR Annual Meeting
The poster highlighted the following findings from the phase I dose-escalation study of MT-6402:MT-6402 has been well tolerated with no drug-related Grade 4 or Grade 5 adverse events observedMT-6402 a
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersProtara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday's pre-market session. The market value of their outstanding shares is at $64.4 million. Candel Therapeutics (N
Molecular Templates 4Q Research and Development Expenses $8.8M >MTEM
Molecular Templates 4Q Research and Development Expenses $8.8M >MTEM
Molecular Templates 4Q EPS 73c >MTEM
Molecular Templates 4Q EPS 73c >MTEM
Press Release: Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templ
Molecular Templates Inc Raises Funds for Clinical Studies
Press Release: Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Molecular
12 Health Care Stocks Moving In Monday's Intraday Session
GainersLandos Biopharma (NASDAQ:LABP) shares rose 173.9% to $21.45 during Monday's regular session. The market value of their outstanding shares is at $66.8 million. The company's, Q4 earnings came ou
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersApplied DNA Sciences (NASDAQ:APDN) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. The market value of their outstanding shares is at $8.3 million. XTL Biopharmaceutic
Stocks to Watch: Brand Engagement Network, Molecular Templates
By Sabela Ojea Brand Engagement Network went public through a special-purpose acquisition company merger. Shares of the provider of personalized customer engagement artificial intelligence surged 80%
Molecular Templates Shares Drop 13% After Bristol Myers Decides to Terminate Research Collaboration
By Sabela Ojea Shares of Molecular Templates dropped 13% to $2.40 in post-market trading on Friday after the company said Bristol Myers Squibb decided to terminate their research collaboration. The
No Data